Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / research-memo-367d-482.docx
research-memo-367d-482.docx
Parties
HARKNESS LLP
Solstice Medical Technologies Inc
SMT Inc
Solstice Biomedical Devices Ltd
Whitmore Valuation Advisors LLC
Growth Equity Advisors III LLC
Stern CPAs LLP
Pemberton Hale LLP
Dates
March 18, 2024
January 29, 2024
March 22, 2024
March 25, 2024
March 8, 2024
December 31, 2023
January 18, 2024
March 1, 2024
March 1, 2034
February 28, 2044
Amounts
$214.5
$11.3
$203.2
$15.136
$189.2
€180.0
$196.2
$1.09
€16.7
€347.6
Obligations
When these conditions are met, the transferor is required to include in its gross income, on an annual basis, amounts determined under the deemed royalty framework described in § 367(d)(2)(A)
These deemed payments are treated as ordinary income to the US transferor and must be recognized on an annual basis over the useful life of the intangible property
The amount of deemed income in each year must be "commensurate with the income attributable to the intangible," incorporating the same standard that governs controlled transactions under IRC § 482
because the deemed inclusion is calculated at a higher rate or because net sales are lower than projected), the difference must be included as additional deemed income by SMT Inc
must recognize for US tax purposes even though it has not received a corresponding cash payment
Accordingly, both transactions must satisfy the arm's-length standard